Noble Life Sciences, a global preclinical CRO dedicated to innovation and scientific discovery, is thrilled to announce its participation in the upcoming annual meeting, where you can find us at Booth 205.
Visit us at Booth 205 to meet the esteemed Noble Life Sciences team and gain insights into our preclinical services capabilities.
The ACT 2023 Annual Meeting event offers a distinctive platform for companies to immerse themselves in a vibrant ecosystem of networking and connecting with a diverse range of toxicologists, industry consultants, and other accomplished professionals and we’re delighted to attend.
The outstanding Scientific Sessions are designed by members to enhance the learning experience, and the collaborative ambiance of the Annual Meeting is a distinctive feature of ACT.
See Us There
Edwin Gershom, Ph.D.
Business Development Manager
Janet Olugbodi, MSc., Ph.D
Study Director, Pharm/Tox